Skip to main content
. Author manuscript; available in PMC: 2018 May 24.
Published in final edited form as: J Clin Psychiatry. 2017 Feb;78(2):196–206. doi: 10.4088/JCP.15r10334

Table 1.

Characteristics of Randomized Controlled Trials of D-Cycloserine Augmented Exposure-Based Cognitive-Behavioral Therapy (CBT)

Trial N Primary Diagnosis Mean Age % Male % Comorbid Depressive Disorders % ComorbidAnxiety Disorders % on SRI Med # of Therapy sessions DCS Dose Timing in hours # of DCS Doses Analysis Type Method Quality
Ressler et al.15 27 SP 46 41 0 0 NR 2 −3 2 ITT 26
Hofmann et al.16 32 SAD 34 67 15 33 33 5 −1 4 COMP 32
Storch et al.17 24 OCD 29 50 38 75 50 12 −4 12 COMP 31
Kushner et al.18 32 OCD 37 38 25 12.5 34.4 4 −2 4 ITT 31
Wilhelm et al.19 23 OCD 39 61 26 43 39 10 −1 10 ITT 31
Guastella et al.20 56 SAD 35 57 16 16 9 5 −1 4 ITT 36
Storch et al.21 30 OCD 12 63 10 27 30 10 −1 7 ITT 36
Otto at al.22 28 PD 37 50 17.9 28.6 54.5 5 −1 3 COMP 28
Litz et al.23 26 PTSD 32 100 30.8 11.5 7.7 6 −1 4 ITT 36
de Kleine et al.24 67 PTSD 38 19 54 42 25 8 −1 6 ITT 36
Nave et al.25 20 SP 37 40 5 0 10 1 −1 1 COMP 30
Farrell et al.26 17 OCD 13 41 12 59 76 9 −1 5 COMP 36
Rodebaugh et al.27 34 SAD 43 33 47 47 35 1 0 2 COMP 32
Hofmann et al.28 169 SAD 33 57 26.6 25.4 0 12 −1 5 ITT 38
Tart et al.29 29 SP 33 24 34 66 0 2 1 2 ITT 35
Mataix-Coles et al. 30 27 OCD 15 52 11 48 26 14 1 10 ITT 34
Scheeringa & Weems31 57 PTSD 12 44 61.4 59.7 10.5 12 −1 7 ITT 38
Rothbaum et al.32 106 PTSD 34 93 77.3 12.2 NR 6 −0.5 5 ITT 29
Difede et al.33 25 PTSD 46 76 64 NR NR 12 −1.5 10 ITT 35
Andersson et al.34 128 OCD 35 42 9 25 24 12 −1 5 ITT 39

NOTE: NR= Not Reported, SP= Specific Phobia, PD= Panic Disorder, SAD= Social Anxiety Disorder, OCD= Obsessive-Compulsive Disorder, PTSD= Posttraumatic Stress Disorder, COMP=Completer Analysis, ITT=Intent-to-Treat Analysis